← Back to Search

Procedure

Virtual Heart Guided Ablation for Ventricular Tachycardia (AVERT-VT Trial)

N/A
Recruiting
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Eligible patients must suffer from VT, thought to be secondary to structural heart disease (scarring).
Eligible patients must be at least 18 years old at the time of enrollment.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

AVERT-VT Trial Summary

This trial is testing a new way to find the best places to zap during ablation procedures for people with VT. The goal is to make the procedure more effective and shorter.

Who is the study for?
This trial is for adults with a rapid heartbeat condition called Ventricular Tachycardia (VT) due to heart scarring. They must have had an MRI scan showing this scarring and be considered suitable for ablation therapy by their heart doctors. People with very poor kidney function, pregnant women, or those who can't undergo an MRI are excluded.Check my eligibility
What is being tested?
The study tests a new 'virtual heart' imaging/simulation method to find the best spots in the heart to perform ablation on patients with VT. It aims to see if targeting these sites helps stop VT and reduces the time needed for the procedure.See study design
What are the potential side effects?
While specific side effects aren't listed here, typical risks of ablation procedures include bleeding or infection at the catheter site, damage to blood vessels or heart tissue, irregular heartbeats, and rarely more serious complications.

AVERT-VT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have ventricular tachycardia due to heart scarring.
Select...
I am at least 18 years old.

AVERT-VT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tachycardia, Ventricular
Secondary outcome measures
Freedom from Ventricular Tachycardia

AVERT-VT Trial Design

1Treatment groups
Experimental Treatment
Group I: Virtual Heart Guided AblationExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,260 Previous Clinical Trials
14,820,750 Total Patients Enrolled

Media Library

Virtual Heart Guided Ablation (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03536052 — N/A
Ventricular Tachycardia Research Study Groups: Virtual Heart Guided Ablation
Ventricular Tachycardia Clinical Trial 2023: Virtual Heart Guided Ablation Highlights & Side Effects. Trial Name: NCT03536052 — N/A
Virtual Heart Guided Ablation (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03536052 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the protocol currently enrolling participants?

"Affirmative, the online resource clinicaltrials.gov shows that this trial is actively enrolling participants. This research effort was launched on September 26th 2022 and last amended on the 30th of that same month. The study calls for a total of 30 people to be recruited from 1 site."

Answered by AI

How many individuals have been recruited for participation in this research?

"Affirmative. Clinicaltrials.gov attests to the fact that this experimental research project, which was initially opened on September 26th 2022, is actively looking for volunteers. A total of 30 individuals are required from a single centre."

Answered by AI
~5 spots leftby Sep 2024